BioCentury | Apr 10, 2018
Distillery Therapeutics

Autoimmune disease

...published online March 28, 2018 doi:10.1021/acs.jmedchem.7b01593 CONTACT: Siavosh Mahboobi, University of Regensburg, Regensburg, Germany email: siavosh.mahboobi@chemie.uni-regensburg.de Claire Quang University of Regensburg Histone...
BioCentury | Feb 3, 2014
Emerging Company Profile

2bind: Results within minutes

...interaction analysis Disease focus: Supply/service Clinical status: N/A Founded: 2012 by Gernot Längst University collaborators: University of Regensburg...
BioCentury | Apr 18, 2013
Distillery Techniques

Technology: Drug delivery

...al. Proc. Natl. Acad. Sci. USA; published online March 25, 2013; doi:10.1073/pnas.1220281110 Contact: Achim Goepferich, University of Regensburg...
BioCentury | May 23, 2011
Company News

SuppreMol, University of Regensburg deal

...it further evaluates the antibody. Further terms were not disclosed. SuppreMol GmbH , Martinsried, Germany University of Regensburg...
BioCentury | May 5, 2011
Distillery Techniques

Technology: Disease models

...G. et al. J. Clin. Invest.; published online April 25, 2011; doi:10.1172/JCI42540 Contact: Stefan Fichtner-Feigl, University of Regensburg...
BioCentury | Nov 4, 2010
Cover Story

LAMbasting brain cancer

...of Sciences . The team was co-led by Eggehard Holler, professor of biochemistry at the University of Regensburg...
...Bethesda, Md. to-BBB technologies B.V. , Leiden, the Netherlands University of Erlangen-Nuremberg , Erlangen, Germany University of Regensburg...
BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...20, 2009; doi:10.1021/jm800988r Contact: Thomas Beckers, Nycomed GmbH, Konstanz, Germany e-mail: Thomas.Beckers@oncotest.de Contact: Siavosh Mahboobi, University of Regensburg...
BioCentury | Feb 12, 2009
Distillery Therapeutics

Indication: Cancer

...M. et al. J. Med. Chem.; published online Jan. 26, 2009; doi:10.1021/jm8013822 Contact: Armin Buschauer, University of Regensburg...
BioCentury | Jan 5, 2004
Emerging Company Profile

Corporate Profile

...IIb Founded: 1998 by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen Corporate partners: Biognostik GmbH University collaborators: University of Regensburg...
BioCentury | Nov 18, 2002
Company News

Capsulution board of directors update

...Germany Business: Drug delivery Appointed: Achim Gopferich, head of the Institute of Pharmacy at the University of Regensburg WIR...
Items per page:
1 - 10 of 16
BioCentury | Apr 10, 2018
Distillery Therapeutics

Autoimmune disease

...published online March 28, 2018 doi:10.1021/acs.jmedchem.7b01593 CONTACT: Siavosh Mahboobi, University of Regensburg, Regensburg, Germany email: siavosh.mahboobi@chemie.uni-regensburg.de Claire Quang University of Regensburg Histone...
BioCentury | Feb 3, 2014
Emerging Company Profile

2bind: Results within minutes

...interaction analysis Disease focus: Supply/service Clinical status: N/A Founded: 2012 by Gernot Längst University collaborators: University of Regensburg...
BioCentury | Apr 18, 2013
Distillery Techniques

Technology: Drug delivery

...al. Proc. Natl. Acad. Sci. USA; published online March 25, 2013; doi:10.1073/pnas.1220281110 Contact: Achim Goepferich, University of Regensburg...
BioCentury | May 23, 2011
Company News

SuppreMol, University of Regensburg deal

...it further evaluates the antibody. Further terms were not disclosed. SuppreMol GmbH , Martinsried, Germany University of Regensburg...
BioCentury | May 5, 2011
Distillery Techniques

Technology: Disease models

...G. et al. J. Clin. Invest.; published online April 25, 2011; doi:10.1172/JCI42540 Contact: Stefan Fichtner-Feigl, University of Regensburg...
BioCentury | Nov 4, 2010
Cover Story

LAMbasting brain cancer

...of Sciences . The team was co-led by Eggehard Holler, professor of biochemistry at the University of Regensburg...
...Bethesda, Md. to-BBB technologies B.V. , Leiden, the Netherlands University of Erlangen-Nuremberg , Erlangen, Germany University of Regensburg...
BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...20, 2009; doi:10.1021/jm800988r Contact: Thomas Beckers, Nycomed GmbH, Konstanz, Germany e-mail: Thomas.Beckers@oncotest.de Contact: Siavosh Mahboobi, University of Regensburg...
BioCentury | Feb 12, 2009
Distillery Therapeutics

Indication: Cancer

...M. et al. J. Med. Chem.; published online Jan. 26, 2009; doi:10.1021/jm8013822 Contact: Armin Buschauer, University of Regensburg...
BioCentury | Jan 5, 2004
Emerging Company Profile

Corporate Profile

...IIb Founded: 1998 by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen Corporate partners: Biognostik GmbH University collaborators: University of Regensburg...
BioCentury | Nov 18, 2002
Company News

Capsulution board of directors update

...Germany Business: Drug delivery Appointed: Achim Gopferich, head of the Institute of Pharmacy at the University of Regensburg WIR...
Items per page:
1 - 10 of 16